Can't PM, as I don't have a paid subscription, but if Phase I ever gets started, their drug may actually work. So I think there is a chance this stock will do well.
I am more confused by this whole generic drug deal. They're strapped for cash so they're getting into the generic drug business? I didn't think it was that easy to do. Actually, I had assumed it would be easier to do a Phase I trial for one drug than it would be to start a generic drug business and get those products to market.
News 
Market Data 
Discover 
